Immune Thrombocytopenia Caused by Glycoprotein IIb/IIIa Inhibitors

This publication has 47 references indexed in Scilit:

• Acute Profound Thrombocytopenia Associated with Anaphylactic Reaction after Abciximab Therapy during Percutaneous Coronary Angioplasty
  Cardiology, 2001
• Abciximab Readministration
  Circulation, 2001
• Drug-Induced Thrombocytopenia: An Updated Systematic Review
  Annals of Internal Medicine, 2001
• Possible anaphylactic reaction to abciximab
  Catheterization and Cardiovascular Interventions, 1999
• Acute profound thrombocytopenia following C7E3 Fab (abciximab) therapy: Case reports, review of the literature and implications for therapy
  American Journal of Hematology, 1999
• Oral platelet glycoprotein IIb/IIIa inhibitors
  Coronary Artery Disease, 1999
• Platelet GPIIb-IIIa blockers
  The Lancet, 1999
• Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization
  Journal of the American College of Cardiology, 1998
• Glycoprotein IIb/IIIa antagonists: Potential induction and detection of drug-dependent antiplatelet antibodies
  American Heart Journal, 1998
• Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
  Journal of Clinical Investigation, 1997